Management of patients with increased risk for familial pancreatic cancer: updated recommendations from the International Cancer of the Pancreas Screening (CAPS) Consortium

Michael Goggins; Kasper A. Overbeek; Randall E. Brand; Sapna Syngal; Marco Del Chiaro; Detlef K. Bartsch; Claudio Bassi; Alfredo Carrato; James J. Farrell; Elliot K. Fishman; Paul Fockens; Thomas M. Gress; Jeanin E. van Hooft; Ralph H. Hruban; Fay Kastrinos; A S Klein; Anne Marie Lennon; Aimee L. Lucas; Walter G. Park; Anil K. Rustgi; Diane M. Simeone; Elena M. Stoffel; Hans F. A. Vasen; Djuna L. Cahen; Marcia Irene Canto; Marco J. Bruno

doi:10.1136/gutjnl-2019-319352

Ask about this paper

Answers are grounded in this paper and cite their sources.

Abstract

Pancreatic surveillance is recommended for selected high-risk individuals to detect early pancreatic cancer and its high-grade precursors, but should be performed in a research setting by multidisciplinary teams in centres with appropriate expertise. Until more evidence supporting these recommendations is available, the benefits, risks and costs of surveillance of pancreatic surveillance need additional evaluation.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Goggins et al. (2019) studied this question.

synapsesocial.com/papers/69d93b58da3af5b1d083614e https://doi.org/10.1136/gutjnl-2019-319352

View Full Paper

Ask AI

Bookmark

Share

Management of patients with increased risk for familial pancreatic cancer: updated recommendations from the International Cancer of the Pancreas Screening (CAPS) Consortium

Ask about this paper

Abstract

Discussion

Cite This Study

Management of patients with increased risk for familial pancreatic cancer: updated recommendations from the International Cancer of the Pancreas Screening (CAPS) Consortium

Ask about this paper

Abstract

Discussion

Cite This Study

Keep reading

Keep reading